Список литературы к Главe 3

1. Kipps T.J., Stevenson F.K., Wu C.J., Croce C.M., Packham G., Wierda W.G. et al. Chronic lymphocytic leukaemia // Nat. Rev. Dis. Primers. 2017. Vol. 3. Article ID 16096.

2. Sant M., Allemani C., Tereanu C., De Angelis R., Capocaccia R., Visser O. et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project // Blood. 2010. Vol. 116, N 19. P. 3724–3734.

3. Chiorazzi N., Rai K.R., Ferrarini M. Chronic lymphocytic leukemia // N. Engl. J. Med. 2005. Vol. 352, N 8. P. 804–815.

4. Crowther-Swanepoel D., Houlston R.S. Genetic variation and risk of chronic lymphocytic leukaemia // Semin. Cancer Biol. 2010. Vol. 20, N 6. P. 363–369.

5. Speedy H.E., Sava G., Houlston R.S. Inherited susceptibility to CLL // Adv. Exp. Med. Biol. 2013. Vol. 792. P. 293–308.

6. Law P.J., Berndt S.I., Speedy H.E., Camp N.J., Sava G.P., Skibola C.F. et al. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia // Nat. Commun. 2017. Vol. 8. Article ID 14175.

7. Hallek M., Cheson B.D., Catovsky D., Caligaris-Cappio F., Dighiero G., Dohner H. et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL // Blood. 2018. Vol. 131, N 25. P. 2745–2760.

8. Scarfo L., Ferreri A.J., Ghia P. Chronic lymphocytic leukaemia // Crit. Rev. Oncol. Hematol. 2016. Vol. 104. P. 169–182.

9. Fischer K., Hallek M. Optimizing frontline therapy of CLL based on clinical and biological factors // Hematology Am. Soc. Hematol. Educ. Program. 2017. Vol. 2017, N 1. P. 338–345.

10. Damle R.N., Ghiotto F., Valetto A., Albesiano E., Fais F., Yan X.J. et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes // Blood. 2002. Vol. 99, N 11. P. 4087–4093.

11. Crassini K., Stevenson W.S., Mulligan S.P., Best O.G. Molecular pathogenesis of chronic lymphocytic leukaemia // Br. J. Haematol. 2019. Vol. 186, N 5. P. 668–684.

12. Herishanu Y., Katz B.Z., Lipsky A., Wiestner A. Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications // Hematol. Oncol. Clin. North Am. 2013. Vol. 27, N 2. P. 173–206.

13. Dearden C. Disease-specific complications of chronic lymphocytic leukemia // Hematology Am. Soc. Hematol. Educ. Program. 2008. P. 450–456.

14. Chiorazzi N., Stevenson F.K. Celebrating 20 Years of IGHV Mutation Analysis in CLL // Hemasphere. 2020. Vol. 4, N 1. P. e334.

15. Chiorazzi N., Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor // Annu. Rev. Immunol. 2003. Vol. 21. P. 841–894.

16. Stevenson F.K., Forconi F., Packham G. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia // Semin. Hematol. 2014. Vol. 51, N 3. P. 158–167.

17. Wiestner A. BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma // Hematology Am. Soc. Hematol. Educ. Program. 2014. Vol. 2014, N 1. P. 125–134.

18. Gemenetzi K., Agathangelidis A., Zaragoza-Infante L., Sofou E., Papaioannou M., Chatzidimitriou A. et al. B cell receptor immunogenetics in B cell lymphomas: immunoglobulin genes as key to ontogeny and clinical decision making // Front. Oncol. 2020. Vol. 10. P. 67.

19. Monroe J.G., Dorshkind K. Fate decisions regulating bone marrow and peripheral B lymphocyte development // Adv. Immunol. 2007. Vol. 95. P. 1–50.

20. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function // Blood. 2008. Vol. 112, N 5. P. 1570–1580.

21. Lefranc M.-P., Lefranc Ge. The Immunoglobulin Factsbook. San Diego : Academic Press, 2001. 457 p.

22. Alt F.W., Zhang Y., Meng F.L., Guo C., Schwer B. Mechanisms of programmed DNA lesions and genomic instability in the immune system // Cell. 2013. Vol. 152, N 3. P. 417–429.

23. Melchers F., Karasuyama H., Haasner D., Bauer S., Kudo A., Sakaguchi N. et al. The surrogate light chain in B-cell development // Immunol. Today. 1993. Vol. 14, N 2. P. 60–68.

24. Victora G.D., Nussenzweig M.C. Germinal centers // Annu. Rev. Immunol. 2012. Vol. 30. P. 429–457.

25. Zhang Y., Garcia-Ibanez L., Toellner K.M. Regulation of germinal center B-cell differentiation // Immunol. Rev. 2016. Vol. 270, N 1. P. 8–19.

26. Hardy R.R., Hayakawa K. B cell development pathways // Annu. Rev. Immunol. 2001. Vol. 19. P. 595–621.

27. Seifert M., Kuppers R. Human memory B cells // Leukemia. 2016. Vol. 30, N 12. P. 2283–2292.

28. Casola S., Otipoby K.L., Alimzhanov M., Humme S., Uyttersprot N., Kutok J.L. et al. B cell receptor signal strength determines B cell fate // Nat. Immunol. 2004. Vol. 5, N 3. P. 317–327.

29. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., Roa S., Kalis S.L., Goodman M.F. et al. The biochemistry of somatic hypermutation // Annu. Rev. Immunol. 2008. Vol. 26. P. 481–511.

30. Xu Z., Zan H., Pone E.J., Mai T., Casali P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond // Nat. Rev. Immunol. 2012. Vol. 12, N 7. P. 517–531.

31. Stavnezer J., Schrader C.E. IgH chain class switch recombination: mechanism and regulation // J Immunol. 2014. Vol. 193, N 11. P. 5370–5378.

32. Martin F., Kearney J.F. Marginal-zone B cells // Nat. Rev. Immunol. 2002. Vol. 2, N 5. P. 323–335.

33. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells // Annu. Rev. Immunol. 2009. Vol. 27. P. 267–285.

34. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E. et al. Human blood IgM «memory» B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire // Blood. 2004. Vol. 104, N 12. P. 3647–3654.

35. Cerutti A., Cols M., Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes // Nat. Rev. Immunol. 2013. Vol. 13, N 2. P. 118–132.

36. Berland R., Wortis H.H. Origins and functions of B-1 cells with notes on the role of CD5 // Annu. Rev. Immunol. 2002. Vol. 20. P. 253–300.

37. Hardy R.R. B-1 B cell development // J. Immunol. 2006. Vol. 177, N 5. P. 2749–2754.

38. Griffin D.O., Holodick N.E., Rothstein T.L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70 // J. Exp. Med. 2011. Vol. 208, N 1. P. 67–80.

39. Pallares N., Lefebvre S., Contet V., Matsuda F., Lefranc M.P. The human immunoglobulin heavy variable genes // Exp. Clin. Immunogenet. 1999. Vol. 16, N 1. P. 36–60.

40. Ruiz M., Pallares N., Contet V., Barbi V., Lefranc M.P. The human immunoglobulin heavy diversity (IGHD) and joining (IGHJ) segments // Exp. Clin. Immunogenet. 1999. Vol. 16, N 3. P. 173–184.

41. Barbie V., Lefranc M.P. The human immunoglobulin kappa variable (IGKV) genes and joining (IGKJ) segments // Exp. Clin. Immunogenet. 1998. Vol. 15, N 3. P. 171–183.

42. Pallares N., Frippiat J.P., Giudicelli V., Lefranc M.P. The human immunoglobulin lambda variable (IGLV) genes and joining (IGLJ) segments // Exp. Clin. Immunogenet. 1998. Vol. 15, N 1. P. 8–18.

43. Xu J.L., Davis M.M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities // Immunity. 2000. Vol. 13, N 1. P. 37–45.

44. Alt F.W., Oltz E.M., Young F., Gorman J., Taccioli G., Chen J. VDJ recombination // Immunol. Today. 1992. Vol. 13, N 8. P. 306–314.

45. Jung D., Alt F.W. Unraveling V(D)J recombination; insights into gene regulation // Cell. 2004. Vol. 116, N 2. P. 299–311.

46. Komori T., Okada A., Stewart V., Alt F.W. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes // Science. 1993. Vol. 261, N 5125. P. 1171–1175.

47. Siminovitch K.A., Moore M.W., Durdik J., Selsing E. The human kappa deleting element and the mouse recombining segment share DNA sequence homology // Nucleic Acids Res. 1987. Vol. 15, N 6. P. 2699–2705.

48. Zuo T., Gautam A., Wesemann D.R. Affinity war: forging immunoglobulin repertoires // Curr. Opin. Immunol. 2019. Vol. 57. P. 32–39.

49. Methot S.P., Di Noia J.M. Molecular mechanisms of somatic hypermutation and class switch recombination // Adv. Immunol. 2017. Vol. 133. P. 37–87.

50. Zanotti K.J., Gearhart P.J. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases // DNA Repair (Amst.). 2016. Vol. 38. P. 110–116.

51. Imkeller K., Wardemann H. Assessing human B cell repertoire diversity and convergence // Immunol. Rev. 2018. Vol. 284, N 1. P. 51–66.

52. Schroeder H.W., Jr., Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire // Immunol. Today. 1994. Vol. 15, N 6. P. 288–294.

53. Johnson T.A., Rassenti L.Z., Kipps T.J. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features // J. Immunol. 1997. Vol. 158, N 1. P. 235–246.

54. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L. et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors // J. Clin. Invest. 1998. Vol. 102, N 8. P. 1515–1525.

55. Agathangelidis A., Darzentas N., Hadzidimitriou A., Brochet X., Murray F., Yan X.J. et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies // Blood. 2012. Vol. 119, N 19. P. 4467–4475.

56. Stamatopoulos K., Belessi C., Hadzidimitriou A., Smilevska T., Kalagiakou E., Hatzi K. et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia // Blood. 2005. Vol. 106, N 10. P. 3575–3583.

57. Hadzidimitriou A., Darzentas N., Murray F., Smilevska T., Arvaniti E., Tresoldi C. et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia // Blood. 2009. Vol. 113, N 2. P. 403–411.

58. Murray F., Darzentas N., Hadzidimitriou A., Tobin G., Boudjogra M., Scielzo C. et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis // Blood. 2008. Vol. 111, N 3. P. 1524–1533.

59. Efremov D.G., Ivanovski M., Siljanovski N., Pozzato G., Cevreska L., Fais F. et al. Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia // Blood. 1996. Vol. 87, N 9. P. 3869–3876.

60. Hashimoto S., Dono M., Wakai M., Allen S.L., Lichtman S.M., Schulman P. et al. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells // J. Exp. Med. 1995. Vol. 181, N 4. P. 1507–1517.

61. Widhopf G.F., 2nd, Rassenti L.Z., Toy T.L., Gribben J.G., Wierda W.G., Kipps T.J. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins // Blood. 2004. Vol. 104, N 8. P. 2499–2504.

62. Tobin G., Soderberg O., Thunberg U., Rosenquist R. V(H)3-21 gene usage in chronic lymphocytic leukemia-characterization of a new subgroup with distinct molecular features and poor survival // Leuk. Lymphoma. 2004. Vol. 45, N 2. P. 221–228.

63. Tobin G., Thunberg U., Karlsson K., Murray F., Laurell A., Willander K. et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia // Blood. 2004. Vol. 104, N 9. P. 2879–2885.